Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-10-09
2007-10-09
Campell, Bruce R. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C435S235100, C424S227100
Reexamination Certificate
active
10857733
ABSTRACT:
The present invention provides particles for the presentation of haptens for the purpose of eliciting an immune response. The amino acid sequences of the monomers which make up the particles are derived from duck hepatitis B virus core protein. The particles may also deliver nucleic acids. The nucleic acids may be delivered for the purpose of enhancing an immune response, or for other purposes such as gene therapy.
REFERENCES:
patent: 4356270 (1982-10-01), Itakura
patent: 4469863 (1984-09-01), Ts'o et al.
patent: 4563423 (1986-01-01), Murray et al.
patent: 4882145 (1989-11-01), Thornton et al.
patent: 5023243 (1991-06-01), Tullis
patent: 5143726 (1992-09-01), Thornton et al.
patent: 5723335 (1998-03-01), Hutcherson et al.
patent: 6025341 (2000-02-01), Wands et al.
patent: 6231864 (2001-05-01), Birkett
patent: 0 092 574 (1992-04-01), None
patent: 07-252300 (1995-10-01), None
patent: WO95/26204 (1995-10-01), None
patent: WO98/40100 (1998-09-01), None
patent: WO99/40934 (1999-08-01), None
Yu, M. et al., A Domain of the Hepadnavirus Capsid Protein Is Specifically Required for DNA Maturation and Virus Assembly, Journal of Virology, 65(5):2511-7, 1991.
Schlicht, H. et al., The Duck Hepatitis B Virus Core Protein Contains a Highly Phosphorylated C Terminus That Is Essential for Replication but Not for RNA Packaging, Journal of Virology, 63(7):2995-3000, 1989.
Mason et al., 36(3) Journal of Virology 829-836 (1980).
Bodey et al., 20 Anticancer Research 2665-2676 (2000).
Dallal, MD et al., 10(2) Surgical Oncology Clinics of North America 433-447 (2001).
Beaucage et al., 22(20) Tetrahedron Letters 1859-62 (1981).
Boggs et al., 7 Antisense & Nucl. Acid Drug Devel. 461-71 (1997).
Bringas, 118 J. Structural Biol. 189-96 (1997).
Carson et al., 186(10) J. Exp. Med. 1621-22 (1997).
Cookson et al., 275 Science 41-42 (1997).
Davis et al., 160 J. Immunol. 870-76 (1998).
Gaffney et al., 29(22) Tetrahedron Letters 2619-22 (1988).
Garegg et al., 27(34) Tetrahedron Letters 4051-54 (1986).
Gilewski et al., 6 Clin. Cancer Res. 1693-1701 (2000).
Gong et al., 97(6) PNAS 2715-18 (2000).
Goodchild, 1(3) Bioconjugate Chem. 165-87 (1990).
Griffiths et al., 67(6) J. Virol. 3191-98 (1993).
Harris et al., 77 Immunol. 315-21 (1992).
Holmberg et al., 25 Bone Marrow Transplant. 1233-41 (2000).
Krieg et al., 374 Nature 546-49 (1995).
Krieg et al., 6 Antisense & Nucl. Acid Drug Devel. 133-39 (1996).
Lipford et al., 27 Eur. J. Immunol. 2340-44 (1997).
Lipford et al., 27 Eur. J. Immunol. 3420-36 (1997).
Milich, 2 Seminars in Immunol. 307-15 (1990).
Milich et al., 754 Ann. NY Acad. Sci. 187-201 (1995).
Pisetsky, 5 Immunity 303-10 (1996).
Raychaudhuri et al., 16 Nature Biotech. 1025-31 (1998).
Schirmbeck et al., 152 J. Immunol. 1110-19 (1994).
Schirmbeck et al., 155 J. Immunol. 4676-84 (1995).
Schödel et al., 66(1) J. Virol. 106-14 (1992).
Schödel et al., 268(2) J. Biol. Chem. 1332-37 (1993).
Schödel et al., 11(2) Vaccine 143-48 (1993).
Schödel et al., 11(2) Int'l Rev. Immunol. 153-65 (1994).
Schödel et al., 98 Behring Inst. Mitt. 114-19 (1997).
Simons et al., 59 Cancer Res. 5160-68 (1999).
Sparwasser et al., 27 Eur. J. Immunol. 1671-79 (1997).
Sparwasser et al., 28 Eur. J. Immunol. 2045-54 (1998).
Stacey et al., 157 J. Immunol. 2116-22 (1996).
Sun et al., 187 (7) J. Exp. Med. 1145-50 (1998).
Uhlmann et al., 90 (4) Chem. Rev. 544-84 (1990).
Wynne et al., 3 Mol. Cell. 771-80 (1999).
Zimmermann et al., 160 J. Immunol. 3627-30 (1998).
Yang et al., 68(1) J. Virol 338-345 (1994).
Weizsacker et al., 24(2) Hepatol 294-299 (1996.).
Kock et al., 72(11) J. Virol 9116-20(1998).
Schödel et al., 44 J. Biotechol. 91-96 (1996).
XP-000891467 Schodel et al. “Hepatitus B Virus Core and e Antigen: Immune Recognition and Use as a Vaccine Carrier Moiety” pp. 104-110; 1996.
Campell Bruce R.
Kinsey Nicole E
Virginia Commonwealth University
Whitham Curtis Christofferson & Cook, P.C.
LandOfFree
Advanced antigen presentation platform does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Advanced antigen presentation platform, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Advanced antigen presentation platform will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3865479